肾臟和胆道支架系统市场按类型、设计、材料、应用和最终用户划分，全球预测（2026-2032）

预计到 2025 年，肾臟和胆道支架系统市场价值将达到 45.1 亿美元，到 2026 年将成长至 47.3 亿美元，到 2032 年将达到 64.8 亿美元，复合年增长率为 5.32%。

关键市场统计数据
基准年 2025	45.1亿美元
预计年份：2026年	47.3亿美元
预测年份 2032	64.8亿美元
复合年增长率 (%)	5.32%

全面概述肾臟和胆道支架系统，说明临床作用、技术权衡以及相关人员的决策因素，以期改善病患预后。

肾臟和胆道支架系统领域融合了介入医学、器材工程和复杂的治疗路径。这些器械对于恢復和维持胆道和泌尿道的通畅性至关重要，其临床效用范围涵盖安宁疗护、术后照护和长期疾病管理。过去十年，支架材料、输送系统和影像引导技术的不断改进，为临床医生提供了更多选择。然而，诸如生物膜形成、支架移位、组织侵入以及可回收性等持续存在的临床挑战，仍然是推动创新发展的关键因素。

技术进步、监管演变、供应链韧性以及以价值为导向的医疗如何共同重塑支架的研发和临床应用？

肾臟和胆道支架领域正受到技术、临床和政策主导因素的共同影响而重塑。材料科学的进步使得支架结构更具适应性和耐用性，而成像和输送系统的改进则提高了微创手术的精确性和可重复性。因此，临床医生有更多机会根据特定的解剖和病理情况选择合适的器械，这影响着器械的使用寿命和术后管理。与这些技术变革相呼应的是，对以价值为导向的医疗服务和综合支付模式的重视，正促使医院和门诊中心优先选择能够降低再入院率、缩短手术时间和减少併发症发生率的器械。

评估 2025 年美国关税调整对医疗设备市场的筹资策略、供应商关係和成本控制重点的影响。

美国2025年实施的新关税为医疗设备製造商和医疗系统的采购和供应链规划增添了新的策略维度。关税调整影响了进口零件和成品的成本结构，迫使企业重新评估供应商关係、合约条款和库存政策。为此，製造商正在探索近岸外包、供应商多元化和提高垂直整合程度等措施，以减轻跨境关税对利润率的影响。

全面的細項分析能够深入洞察类型、设计、材质、临床应用和最终用户环境如何共同决定设备选择和创新重点。

细分市场分析揭示了器械特性和临床应用背景如何共同驱动产品差异化和市场接受度。就类型而言，当需要精确的径向支撑力和可预测的展开时，球囊扩张型支架往往是首选；而自动扩张型支架则能为迂曲的血管解剖结构和动态管腔提供良好的贴合性和持续的向外支撑力。从类型到设计，覆膜支架和裸支架之间的差异直接影响临床权衡。覆膜支架可以限制组织侵入并简化取出过程，但可能增加移位和阻塞的风险。另一方面，裸支架有利于排放透过侧支引流，但随着时间的推移，可能更容易发生组织侵入。

区域差异分析：阐述基础设施、报销模式和临床实务的差异如何导致产品引进和商业化策略的差异。

区域趋势揭示了美洲、欧洲、中东和非洲以及亚太地区医疗基础设施、报销框架和临床医生实践模式差异所导致的不同的技术采纳路径。在美洲，先进的介入治疗网络和高手术量促进了创新治疗系统和精密设备的快速普及。同时，完善的采购流程促使采购者在选择产品时优先考虑生命週期成本和疗效。另一方面，在欧洲、中东和非洲，报销模式和法规环境的差异凸显了该地区的多样性。在这个复杂的区域内，某些市场强调真实世界安全性数据和长期后续观察，而其他市场则优先考虑成本控制和集中采购。

策略竞争概览：产品创新、监管策略和供应链选择决定了市场领导和挑战者。

肾胆支架领域的企业竞争体现在产品创新、监管应对力与策略联盟三者之间的平衡。主要企业正致力于渐进式和基础性创新，以应对移位、阻塞和回收等挑战，同时优化输送系统以缩短手术时间并提高术者效率。同时，精明的新兴参与企业和中型市场参与者则专注于细分市场差异化，例如特殊涂层、涂层化学以及整合药物释放型和抗菌功能的组合装置，以在特定临床领域获得市场份额。

经营团队需采取具体策略行动，协调设备研发、临床证据和供应链韧性，以追求永续的商业性优势。

产业领导者应采取切实可行的措施，平衡临床价值与商业性可行性。首先，优先投资于能够显着减少再次手术需求和降低併发症发生率的功能，以满足关注总成本和以患者为中心的治疗结果的利益相关人员的需求。其次，将上市后监测纳入产品生命週期，以产生可靠的真实世界数据，从而支持临床医生采纳和监管合规。这可以透过註册合作和数位化追踪解决方案来实现。第三，透过关键零件采购多元化、探索区域製造伙伴关係关係以及实施灵活的库存策略来增强供应链韧性，从而减轻关税和物流中断的影响。

采用严谨的混合方法研究途径，结合临床医师意见、技术审查、监管分析与检验，得出可靠的策略见解。

本分析的研究方法透过对临床实务趋势、医疗设备设计原则和商业策略进行质性综合分析，得出可操作的见解。主要资料来源包括临床医生访谈、技术白皮书、监管指导文件和供应链评估，旨在阐明器械设计的权衡取舍、重要性以及临床应用案例。二级资讯来源包括对同行评审的临床文献和已发布的监管决策的分析，用于评估安全性、性能预期和证据生成方法。

指导经营团队决策和策略调整，以实现将临床需求与商业性和营运重点结合的综合成果。

本分析整合了影响肾臟和胆道支架市场的临床、商业性和营运等各个方面，旨在为行业领导者提供一致的决策框架。临床方面，当务之急显而易见：器械必须减轻手术负担、最大限度地减少併发症，并支持以病人为中心的诊疗路径。商业性，能够使器械特性与支付方预期相符，并透过真实世界数据证明其价值的企业将获得成功。在营运方面，供应链的韧性和区域生产考量是决定可靠性和成本稳定性的关键因素。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 市场进入策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 肾臟和胆道支架系统市场（按类型划分）

• 球囊扩张型支架
• 自动扩张型支架

9. 肾臟和胆道支架系统市场（依设计划分）

• 覆盖类型
• 未涂层

10. 肾臟和胆道支架系统市场（依材料分类）

• 由金属製成
  • 镍钛诺
  • 不銹钢
• 由聚合物製成
  • 聚四氟乙烯
  • 硅酮

第十一章 按应用分類的肾臟和胆道支架系统市场

• 良性胆道狭窄
  • 术后狭窄
  • 原发性硬化性胆管炎
• 恶性胆道阻塞
  • 胆管癌
  • 胰臟癌
• 输尿管阻塞
  • 良性
  • 恶性
• 输尿管狭窄
  • 良性
  • 恶性

12. 按最终用户分類的肾臟和胆道支架系统市场

• 门诊手术中心
• 医院和诊所
  • 综合医院
  • 专科诊所

13. 各地区肾臟及胆道支架系统市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

14. 肾臟和胆道支架系统市场（按组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

15. 各国肾臟及胆道支架系统市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

16. 美国肾臟及胆道支架系统市场

第十七章 中国肾臟与胆道支架系统市场

第十八章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Abbott Laboratories
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Boston Scientific Corporation
• Cook Medical LLC
• Endo-Flex GmbH by Medi-Globe
• Johnson & Johnson Services, Inc.
• Medtronic plc
• Merit Medical Systems, Inc.
• Nanjing Micro-Tech Medical（Group）Co., Ltd.
• Nipro Corporation
• Olympus Corporation
• Sahajanand Medical Technologies Limited
• Teleflex Incorporated
• Terumo Corporation
• WL Gore & Associates, Inc.

The Renal & Biliary Stent System Market was valued at USD 4.51 billion in 2025 and is projected to grow to USD 4.73 billion in 2026, with a CAGR of 5.32%, reaching USD 6.48 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 4.51 billion
Estimated Year [2026]	USD 4.73 billion
Forecast Year [2032]	USD 6.48 billion
CAGR (%)	5.32%

A comprehensive orientation to renal and biliary stent systems that explains clinical roles, engineering trade-offs, and stakeholder decision drivers for better patient outcomes

The renal and biliary stent system landscape sits at the intersection of interventional medicine, device engineering, and complex care pathways. These devices are integral to restoring and maintaining luminal patency in the biliary and urinary tracts, and their clinical utility spans palliative management, postoperative care, and long-term disease control. Over the past decade, incremental improvements in stent materials, delivery systems, and imaging guidance have coalesced into a more refined set of options for clinicians, yet persistent clinical challenges-such as biofilm formation, migration, tissue ingrowth, and the need for retrievability-continue to shape innovation priorities.

Clinicians, manufacturers, and procurement professionals now evaluate stent choices through a multidimensional lens that includes procedural efficiency, patient-centered outcomes, and total cost of care. As a result, the discussion has shifted from device-centric specifications to broader considerations of clinical pathways and systems-level value. This introduction frames the subsequent analysis by clarifying the clinical imperatives that drive device selection, the engineering trade-offs implicit in design and material choices, and the regulatory and reimbursement realities that influence how these products are brought to market and adopted in practice.

In sum, appreciating both the technical attributes of renal and biliary stents and the contextual demands of care delivery is essential for stakeholders seeking to prioritize development, refine product portfolios, or optimize procurement strategies. This foundation enables a focused exploration of the transformative dynamics, segmentation nuances, regional variations, and competitive behaviors that follow.

How technological advancements, regulatory evolution, supply chain resilience, and value-based care are collectively reshaping stent development and clinical adoption

The landscape for renal and biliary stents is being reshaped by a convergence of technological, clinical, and policy-driven forces. Advancements in materials science have enabled more compliant and durable constructs, while improvements in imaging and delivery systems have made minimally invasive procedures more precise and reproducible. Consequently, clinicians are increasingly able to tailor device choice to specific anatomical and pathological circumstances, which in turn influences device lifecycle and post-procedural management. Alongside these technological shifts, an emphasis on value-based care and bundled payment models has prompted hospitals and ambulatory centers to prioritize devices that reduce readmissions, shorten procedure times, and lower complication rates.

Regulatory pathways are also evolving, with authorities placing greater emphasis on real-world evidence and post-market surveillance. This creates both opportunities and obligations for manufacturers to demonstrate long-term safety and performance beyond traditional bench testing. Concurrently, supply chain resilience and manufacturing agility have become strategic differentiators following recent global disruptions. Organizations that invest in diversified sourcing, robust quality systems, and flexible production processes are better positioned to manage disruptions and meet clinician demand.

Finally, the patient experience is increasingly central to innovation agendas. Initiatives that reduce the need for repeat interventions, improve symptomatic relief, and enable outpatient management are gaining priority. Together, these transformative shifts redefine competitive advantage and suggest that the next wave of differentiation will come from integrated solutions that combine superior device characteristics with services that optimize clinical pathways and patient outcomes.

Assessment of how 2025 tariff adjustments in the United States are influencing procurement strategies, supplier relationships, and cost-management priorities in device markets

The introduction of new tariff measures in the United States during 2025 has added an additional strategic dimension to procurement and supply chain planning for medical device companies and health systems alike. Tariff adjustments have influenced cost structures for imported components and finished devices, prompting organizations to reassess supplier relationships, contract terms, and inventory policies. In response, manufacturers have explored near-shoring, supplier diversification, and increased vertical integration to mitigate the margin impact of cross-border duties.

Procurement functions within hospitals and ambulatory centers have reacted by revisiting total-cost-of-ownership considerations and placing higher emphasis on predictable pricing, lead times, and contractual protections. As a result, negotiation dynamics between suppliers and buyers have shifted toward multi-year agreements with built-in contingencies and collaborative forecasting. This, in turn, has implications for smaller innovators whose supply chains are more exposed to tariff volatility and who may face heightened barriers to entry unless they secure strategic partnerships or localized manufacturing capabilities.

Importantly, the tariff environment has also accelerated conversations around value engineering and cost optimization in device design. Manufacturers are balancing material choices and manufacturing processes to preserve clinical performance while managing landed costs. In summary, the cumulative effect of tariff changes has been to elevate supply chain strategy and procurement sophistication as central elements of commercial planning, influencing how organizations prioritize investments and structure go-to-market approaches.

Comprehensive segmentation insights detailing how type, design, material, clinical application, and end-user settings jointly determine device selection and innovation focus

Segmentation analysis reveals how device characteristics and clinical contexts jointly drive product differentiation and adoption patterns. When types are compared, balloon-expandable stents tend to be selected where precise radial force and predictable deployment are critical, while self-expanding stents offer conformability and continuous outward force suited to tortuous anatomy and dynamic lumens. Moving from type to design, the covered versus uncovered distinction directly affects clinical trade-offs: covered designs reduce tissue ingrowth and can simplify removal but may increase the risk of migration and occlusion, whereas uncovered designs facilitate biliary drainage through side branches but can be prone to ingrowth over time.

Material selection further nuances device performance and manufacturing complexity. Metallic constructs, commonly fabricated from nitinol or stainless steel, provide predictable radial strength and fatigue resistance; nitinol offers superior conformability and shape-memory behavior, while stainless steel can deliver cost advantages and specific mechanical profiles. Polymeric alternatives-including polytetrafluoroethylene and silicone-offer distinct biocompatibility and flexibility characteristics and are frequently used in covered or entirely polymeric designs to mitigate biofilm adherence and facilitate retrievability. These material choices have downstream implications for sterilization, shelf life, and imaging compatibility.

Clinical application is another pivotal lens. Devices intended for benign biliary strictures, which include post-surgical strictures and those arising from primary sclerosing cholangitis, prioritize long-term patency and low complication rates; by contrast, stents used for malignant biliary obstruction-such as those associated with cholangiocarcinoma or pancreatic cancer-often emphasize palliation and durable lumen maintenance in the context of limited life expectancy. Ureteral obstructions and ureteral strictures, whether benign or malignant, require attention to ureteral peristalsis, encrustation tendencies, and the need for exchange or removal. Finally, end-user setting shapes procurement and product design considerations: ambulatory surgical centers tend to prioritize single-use, easy-to-deploy systems that support rapid turnover, whereas hospitals and specialty clinics may favor devices that offer retrievability, advanced imaging compatibility, and supply chain consistency. The interplay of these segmentation dimensions drives targeted product development, regulatory strategy, and commercialization planning.

Regional differentiation analysis explaining how infrastructure, reimbursement models, and clinical practice variations drive divergent adoption and commercialization strategies

Regional dynamics reveal differentiated adoption pathways shaped by healthcare infrastructure, reimbursement frameworks, and clinician practice patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced interventional networks and high procedure volumes support rapid uptake of innovative delivery systems and premium device features, while procurement sophistication leads buyers to weigh life-cycle costs and outcomes when selecting products. By contrast, Europe, the Middle East & Africa exhibit heterogeneity driven by divergent reimbursement models and regulatory environments; certain markets within this combined region place a premium on real-world safety data and long-term surveillance, whereas others emphasize cost containment and centralized purchasing.

Asia-Pacific encompasses a broad spectrum of healthcare maturity, from highly specialized tertiary centers that quickly adopt novel devices to regions where infrastructure constraints favor simpler, cost-effective solutions. Reimbursement policies and public procurement practices in many Asia-Pacific markets influence device standardization and the pace of technology diffusion. Across all regions, common themes emerge: the need for robust clinician training programs, the importance of post-market evidence to support clinical guidelines, and the role of local manufacturing or supply partnerships in ensuring availability. These regional contrasts inform market-entry strategies and indicate that a one-size-fits-all commercialization approach will be less effective than regionally tailored tactics that align with payer expectations, clinical capacity, and logistical realities.

Strategic competitive overview showing how product innovation, regulatory strategy, and supply chain choices are defining market leaders and challengers

Competitive behavior among companies in the renal and biliary stent arena reflects a balance between product innovation, regulatory acumen, and strategic partnerships. Leading firms are investing in incremental and platform innovations that address migration, occlusion, and retrievability while simultaneously optimizing delivery systems to reduce procedure time and improve operator ergonomics. At the same time, savvy entrants and mid-tier players are focusing on niche differentiation-such as specialized coverings, coating chemistries, or combination devices that integrate drug elution or antibacterial features-to carve share in defined clinical segments.

Regulatory strategy has become a significant determinant of market positioning; companies that demonstrate robust post-market surveillance and generate real-world evidence are better able to navigate approvals and secure clinician trust. Collaboration with clinical investigators and health systems is also a feature of successful commercial models, enabling iterative design improvements and early adoption within centers of excellence. Moreover, supply chain strategy, including manufacturing footprint and supplier diversity, is increasingly visible in competitive comparisons. Firms that align their commercial narratives with demonstrable outcomes, procurement value, and clinician satisfaction tend to sustain longer-term relationships with high-volume users and payers. Thus, competitive advantage is being defined not solely by device specs but by an integrated approach that couples engineering excellence with regulatory, clinical, and operational capabilities.

Concrete strategic actions for executives to align device development, clinical evidence, and supply chain resilience in pursuit of sustainable commercial advantage

Industry leaders should pursue a set of pragmatic actions that align clinical value with commercial viability. First, prioritize investments in features that demonstrably reduce the need for repeat procedures and lower complication rates, thereby resonating with stakeholders focused on total cost and patient-centered outcomes. Second, integrate post-market surveillance into product lifecycles to generate robust real-world evidence that supports clinician adoption and regulatory compliance; this can be achieved through registry partnerships and digital follow-up solutions. Third, strengthen supply chain resilience by diversifying critical component sourcing, exploring regional manufacturing partnerships, and implementing flexible inventory strategies to mitigate tariff and logistics disruptions.

In parallel, commercial teams should tailor market-entry strategies to regional payer and procurement dynamics, ensuring that pricing and value propositions reflect local expectations. Collaborations with clinical champions and early adopter sites remain essential for generating clinical momentum; therefore, investing in training, proctoring, and peer-to-peer education will accelerate uptake. Finally, consider service-based offerings and bundled solutions that combine devices with procedural support, data analytics, or warranty arrangements to create differentiated value propositions. Collectively, these actions will help companies reduce adoption friction, improve patient outcomes, and sustain commercially viable portfolios in a complex and evolving environment.

Rigorous mixed-methods research approach combining clinician input, technical review, regulatory analysis, and validation to produce defensible strategic insights

The research approach underpinning this analysis combined qualitative synthesis of clinical practice trends, device engineering principles, and commercial strategy to produce actionable insights. Primary inputs included clinician interviews, technical white papers, regulatory guidance documents, and supply chain assessments, all of which were synthesized to characterize device design trade-offs, material implications, and clinical use cases. Secondary sources comprised peer-reviewed clinical literature and publicly available regulatory decisions that informed assessments of safety, performance expectations, and evidence-generation practices.

To ensure analytical rigor, findings were triangulated across multiple data streams and validated through expert consultations with interventional specialists, procurement leaders, and regulatory affairs professionals. Where appropriate, sensitivity checks and scenario-based reasoning were employed to evaluate the robustness of strategic implications against variations in reimbursement policy and supply chain disruption. Limitations of the methodology include the variability of reporting across regions and the evolving nature of real-world evidence; therefore, conclusions emphasize durable strategic principles rather than time-bound quantitative estimates. Overall, the methodology is designed to provide a defensible basis for decision-making while acknowledging areas where additional primary data collection could further refine tactical choices.

Integrated conclusion that ties clinical imperatives to commercial and operational priorities to guide executive decision-making and strategic alignment

This analysis synthesizes the clinical, commercial, and operational dimensions that shape the renal and biliary stent environment to provide leaders with a cohesive decision framework. Clinically, the imperative is clear: devices must reduce procedural burden, minimize complications, and support patient-centered care pathways. Commercially, success will accrue to organizations that align device features with payer expectations and that substantiate value through real-world evidence. Operationally, supply chain resilience and regional manufacturing considerations have become key determinants of reliability and cost stability.

Taken together, these perspectives indicate that competitive advantage will increasingly rest on integrated solutions that combine superior device attributes with evidence generation, clinician enablement, and robust procurement support. Strategic priorities should therefore emphasize cross-functional alignment across R&D, clinical affairs, and commercial teams to ensure that product roadmaps respond to both procedural realities and systemic incentives. In closing, stakeholders who adopt a holistic approach-balancing technical innovation with evidence, operational robustness, and regional market intelligence-will be best positioned to deliver sustained clinical and commercial impact.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Renal & Biliary Stent System Market, by Type

• 8.1. Balloon-Expandable Stent
• 8.2. Self-Expanding Stent

9. Renal & Biliary Stent System Market, by Design

• 9.1. Covered
• 9.2. Uncovered

10. Renal & Biliary Stent System Market, by Material

• 10.1. Metallic
  • 10.1.1. Nitinol
  • 10.1.2. Stainless Steel
• 10.2. Polymeric
  • 10.2.1. Polytetrafluoroethylene
  • 10.2.2. Silicone

11. Renal & Biliary Stent System Market, by Application

• 11.1. Benign Biliary Stricture
  • 11.1.1. Post Surgical Stricture
  • 11.1.2. Primary Sclerosing Cholangitis
• 11.2. Malignant Biliary Obstruction
  • 11.2.1. Cholangiocarcinoma
  • 11.2.2. Pancreatic Cancer
• 11.3. Ureteral Obstruction
  • 11.3.1. Benign
  • 11.3.2. Malignant
• 11.4. Ureteral Stricture
  • 11.4.1. Benign
  • 11.4.2. Malignant

12. Renal & Biliary Stent System Market, by End Users

• 12.1. Ambulatory Surgical Centers
• 12.2. Hospitals & Clinics
  • 12.2.1. General Hospitals
  • 12.2.2. Specialty Clinics

13. Renal & Biliary Stent System Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Renal & Biliary Stent System Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Renal & Biliary Stent System Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Renal & Biliary Stent System Market

17. China Renal & Biliary Stent System Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Abbott Laboratories
• 18.6. B. Braun Melsungen AG
• 18.7. Becton Dickinson and Company
• 18.8. Boston Scientific Corporation
• 18.9. Cook Medical LLC
• 18.10. Endo-Flex GmbH by Medi-Globe
• 18.11. Johnson & Johnson Services, Inc.
• 18.12. Medtronic plc
• 18.13. Merit Medical Systems, Inc.
• 18.14. Nanjing Micro-Tech Medical (Group) Co., Ltd.
• 18.15. Nipro Corporation
• 18.16. Olympus Corporation
• 18.17. Sahajanand Medical Technologies Limited
• 18.18. Teleflex Incorporated
• 18.19. Terumo Corporation
• 18.20. W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 88. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 89. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 90. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 91. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 93. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 94. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 95. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 96. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 97. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 98. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 99. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 101. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 102. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 103. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 104. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 105. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 106. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 107. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 108. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 109. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 110. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 111. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 112. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 113. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 114. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 115. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 116. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 117. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 118. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 119. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 120. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 121. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 122. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 123. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 124. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 125. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 126. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 127. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 128. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 129. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 130. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 131. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 141. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 142. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 143. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 145. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 146. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 147. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 148. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 149. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 150. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 151. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 152. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 153. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 154. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 155. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 156. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 157. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 158. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 159. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 160. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 161. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 162. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 163. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 164. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 165. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 166. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 167. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 168. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 169. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 170. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 171. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 172. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 173. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 174. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 175. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 176. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 177. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 178. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 179. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 180. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 181. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 182. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 183. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 184. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 185. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 186. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 187. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 188. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 189. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 190. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 191. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 192. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 193. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 194. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 195. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 196. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 197. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 198. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 199. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 200. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 201. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 202. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 203. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 204. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 205. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 206. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 207. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 208. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 209. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 210. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 211. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 212. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 213. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 214. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 215. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 216. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 217. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 218. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 219. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 220. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 221. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 222. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 223. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 224. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 225. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 226. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 227. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 228. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 229. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 230. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 231. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 232. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 233. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 234. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 235. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 236. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 237. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 238. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 239. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 240. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 241. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 242. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 243. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 244. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 245. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 246. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 247. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 248. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 249. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 250. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 251. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 252. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 253. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 254. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 255. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 256. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 257. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 258. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 259. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 260. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 261. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 262. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 263. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 264. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 265. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 266. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 267. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 268. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 269. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 270. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 271. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 272. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 273. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 274. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 275. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 276. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 277. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 278. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 279. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 280. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 281. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 282. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 283. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 284. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 285. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 286. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 287. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 288. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 289. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
• TABLE 290. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 291. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
• TABLE 292. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
• TABLE 293. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 294. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
• TABLE 295. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
• TABLE 296. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 297. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
• TABLE 298. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 299. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 300. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
• TABLE 301. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
• TABLE 302. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)